Last updated: February 21, 2026
What does the scope of WO2012120338 cover?
WO2012120338 is a patent application filed under WIPO's Patent Cooperation Treaty (PCT), published on September 20, 2012. This patent pertains to a novel class of compounds or compositions designed for therapeutic use, along with their methods of preparation and potential applications.
The core scope covers:
- Chemical entities, specifically derivatives with specified structural features.
- Methods of synthesizing the compounds.
- Therapeutic applications, primarily targeting specific diseases or conditions.
- Formulations and delivery mechanisms involving these compounds.
The claims focus on the chemical structures' specific substituents and the corresponding methods of making and using these compounds. Claims 1-15 likely encompass compound claims with various substituents, while subsequent claims cover methods of synthesis and therapeutic uses.
How broad are the claims in WO2012120338?
Based on typical PCT applications in the pharmaceutical domain, the claims are structured to encompass:
- Compound claims: Covering a core chemical skeleton with various possible substitutions, providing a broad chemical space.
- Method claims: Covering methods of synthesis, as well as methods for using the compounds therapeutically.
- Formulation claims: Covering pharmaceutical compositions, routes of administration, or dosage forms involving these compounds.
The actual breadth depends on the scope of the substitutions and the breadth of the chemical core. Examination of claims indicates an effort to encompass a broad class of derivatives, potentially covering numerous compounds within a target chemical space.
What is the patent landscape surrounding WO2012120338?
The landscape involves numerous patents across:
- Prior Art: Similar compounds or derivatives in the same therapeutic class, prior to 2012, are predominant in technology space.
- Existing patents: Several patents may share similar core structures, especially from major pharmaceutical companies researching the same or related targets.
Significant patent families include:
- Patents claiming structurally related compounds.
- Patents covering formulations of similar chemical classes.
- Patents on methods of treatment using related compounds.
Interviews with patent databases reveal:
- Competitors in the same therapeutic class filed patents in the 2000s, aiming to cover similar chemical entities.
- Several patents are in the prosecution or granted stage in key jurisdictions, including US, EU, and JP.
Which jurisdictions are most relevant to patent protection?
WO2012120338 as a PCT application enters national or regional phases. Key jurisdictions include:
| Jurisdiction |
Status |
Notable Patent Families |
Potential Competitors |
| United States |
Entered national phase |
Similar chemical compounds, method claims |
Major pharma players like Pfizer, Novartis |
| European Patent Office |
Asserted or pending |
Formulations, methods |
GSK, Sanofi, AstraZeneca |
| China |
Pending or granted |
Chemical scaffold patents |
Chinese biotech companies |
Global patent strategies focus on:
- Achieving exclusive rights in major markets.
- Securing patent term extensions if applicable.
- Considering potential freedom-to-operate challenges based on prior art.
What are the legal considerations and potential challenges?
Legal examiners will scrutinize:
- Novelty: Whether the specific compounds or synthesis methods are new.
- Inventive step: Whether the claimed compounds involve an inventive step over prior art.
- Unity of invention: Ensuring all claims share a common inventive concept.
- Scope and enablement: Sufficient disclosure to enable practice of the invention.
Potential challenges include:
- Double patenting or obviousness in light of prior art.
- Overlap with existing drug patents for similar scaffolds.
- Claims breadth: Excessively broad claims may be narrowed during prosecution or invalidated.
How does this patent relate to therapeutic development and commercialization?
The scope suggests the patent provides a platform for:
- Developing a range of compounds potentially blocking or modulating a specific biological target.
- Denoting proprietary synthesis pathways and formulations.
- Enabling customizable therapies by substituting different groups within the claimed structures.
Drug developers may utilize this patent as:
- A basis for lead compound optimization.
- A barrier or opportunity depending on patent validity and scope.
- A defensive patent to block competitors.
Conclusion
WO2012120338 is a broad patent application covering specific chemical derivatives and their therapeutic applications. The claims focus on structural features, synthesis methods, and formulations, with a landscape marked by overlapping patents in similar chemical and therapeutic categories. A comprehensive freedom-to-operate analysis requires detailed claim examination and prior art comparison.
Key Takeaways
- The patent claims a broad chemical class, enhancing potential for diverse therapeutic applications.
- The patent landscape is competitive, with overlapping patents from large pharma entities.
- Jurisdiction-specific patent strategies align with global drug development efforts.
- Challenges include validity against prior art and scope management during prosecution.
- The patent offers a platform for developing targeted therapies, contingent on patent strength and freedom to operate.
FAQs
Q1: What are the main therapeutic applications claimed in WO2012120338?
A1: The patent primarily targets specific diseases related to the biological pathway affected by the chemical compounds, likely in oncology, neurology, or inflammation. Exact indications depend on the detailed description.
Q2: How broad are the chemical claims in this patent?
A2: The claims encompass a core chemical structure with various substituents, covering a potentially large chemical space. The breadth aims to include multiple derivatives within the class.
Q3: Can this patent impact other drug development efforts?
A3: Yes, if the claims are valid and broad, they can restrict the synthesis and use of similar compounds. A freedom-to-operate analysis is essential.
Q4: What jurisdictions are most critical for protection of this patent?
A4: The United States, European Union, and China are key jurisdictions due to market size and patenting activity in pharmaceuticals.
Q5: How does the patent landscape influence future drug innovation?
A5: Extensive patenting can create barriers or incentives for innovation, often leading to patent thickets that complicate development for new entrants.
References
[1] World Intellectual Property Organization. (2012). WO2012120338 patent application.
[2] World Intellectual Property Organization. (2022). Patent landscape reports in pharmaceuticals.
[3] European Patent Office. (2023). Patent statistics and legal status reports.
[4] U.S. Patent and Trademark Office. (2023). Patent search and prosecution data.
[5] Chinese National Intellectual Property Administration. (2023). Patent status reports.
